Format

Send to

Choose Destination
See comment in PubMed Commons below
Int J Cardiol. 2016 Apr 1;208:109-14. doi: 10.1016/j.ijcard.2015.12.009. Epub 2015 Dec 15.

Effects of liraglutide on no-reflow in patients with acute ST-segment elevation myocardial infarction.

Author information

  • 1Department of Cardiology, PLA General Hospital, at Beijing, China.
  • 2Department of Cardiology, PLA General Hospital, at Beijing, China. Electronic address: cyundai@vip.163.com.

Abstract

BACKGROUND:

The 'no-reflow' phenomenon after a percutaneous coronary intervention (PCI) in patients with acute ST-segment elevation myocardial infarction (STEMI) is a strong predictor of both short- and long-term mortality. Glucagon-like peptide-1 (GLP-1) exerts a cardioprotective effect during ischemia reperfusion injury. We planned to evaluate the effects of liraglutide on myocardial no-reflow after PCI for STEMI.

METHODS:

A total of 284 patients with STEMI undergoing PCI were enrolled in this study between September 2013 and March 2015. Of these, 210 patients were randomized 1:1 to receive either liraglutide or placebo 30 min before PCI (1.8 mg).

RESULTS:

The primary end point, the prevalence of no-reflow, was significantly lower in the liraglutide group than in the control group (5% vs. 15%, P=0.01). Administration of liraglutide was consistently identified as a significant determinant for no-reflow ratio. There was a significant decrease in serum high-sensitivity C-reactive protein levels at 6-hour reperfusion in the liraglutide group compared to the control group (0.87 ± 0.09 mg/dL vs. 0.96 ± 0.10mg/dL, P<0.001). During a 3-month follow-up period, no difference was observed in the incidence of major adverse cardiovascular event.

CONCLUSIONS:

Liraglutide may be associated with less no-reflow in STEMI, which should be confirmed by larger-scale trials.

KEYWORDS:

Acute ST-segment elevation myocardial infarction; Glucagon-like peptide-1; No-reflow; Percutaneous coronary intervention; Reperfusion injury

PMID:
26849684
DOI:
10.1016/j.ijcard.2015.12.009
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center